Preservation of Inferior Mesenteric Artery Could Improve Sexual Function After Laparoscopic Colorectal Resection for Diverticular Disease (IMAPSEX)

February 8, 2021 updated by: Francesco Saverio Mari, MD, PhD, FACS, University of Roma La Sapienza
This study aims to evaluate whether IMA sparing may represent an advantage in terms of reduced incidence and severity of sexual dysfunctions after colorectal resections for diverticular disease (DD).

Study Overview

Detailed Description

Enrolled patients were randomly divided into 2 treatment groups. In the first group (IMAP) the IMA was preserved sectioning the sigmoid arteries near colonic wall while, in the second group (IMAS) the IMA was sectioned immediately below the origin of the left colic artery. Incidence and severity of sexual dysfunction and QoL were assessed by four validated questionnaire administered 6,12 months and 5 and 8 years after surgery.

Study Type

Interventional

Enrollment (Actual)

300

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Rome, Italy, 00188
        • Azienda Ospedaliera Sant'Andrea

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • diverticular disease
  • Diverticulitis
  • BMI under 35 Kg/mq
  • ASA score from I to III
  • Standardized sigmoid, left colon or rectal resection

Exclusion Criteria:

  • complicated diverticulitis (Hinchey III-IV)
  • previous abdominal surgery or prostatic and/or gynecological resections
  • adverse local condition or the need of multiorgan resection or stoma creation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: IMAP
Inferior Mesenteric Artery Preservation Performing left hemicolectomy and anterior rectal resection the IMA was preserved ligating close to the colonic wall the sigmoids arteries.
Performing left hemicolectomy the IMA was preserved ligating close to the colonic wall the sigmoids arteries.
Active Comparator: IMAS
Inferior Mesenteric Artery Ligation Performing left hemicolectomy the IMA is ligated and sectioned after the origin of left colic artery
Performing left hemicolectomy the IMA is ligated and sectioned after the origin of left colic artery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sexual Function Male 1
Time Frame: 12 month after surgery
assess the patients' sexual disorders with International Index of Erectile Function (IIEF)
12 month after surgery
Sexual Function Male 2
Time Frame: 5 years after surgery
assess the patients' sexual disorders with International Index of Erectile Function (IIEF)
5 years after surgery
Sexual Function Male 3
Time Frame: 8 years after surgery
assess the patients' sexual disorders with International Index of Erectile Function (IIEF)
8 years after surgery
Sexual Function Female 1
Time Frame: 12 months after surgery
assess the patients' sexual disorders withFemale Sexual Function Index (FSFI)
12 months after surgery
Sexual Function Female 2
Time Frame: 5 years after surgery
assess the patients' sexual disorders withFemale Sexual Function Index (FSFI)
5 years after surgery
Sexual Function Female 3
Time Frame: 8 years after surgery
assess the patients' sexual disorders withFemale Sexual Function Index (FSFI)
8 years after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Life 1
Time Frame: 12 months after surgery
The impact of sexual disorders in QoL was evaluated using EORTC QLQ-30
12 months after surgery
Quality of Life 2
Time Frame: 5 years after surgery
The impact of sexual disorders in QoL was evaluated using EORTC QLQ-30
5 years after surgery
Quality of Life 3
Time Frame: 8 years after surgery
The impact of sexual disorders in QoL was evaluated using EORTC QLQ-30
8 years after surgery
Quality of Life 4
Time Frame: 12 months after surgery
The impact of sexual disorders in QoL was evaluated using EORTC QLQ-CR29
12 months after surgery
Quality of Life 5
Time Frame: 5 years after surgery
The impact of sexual disorders in QoL was evaluated using EORTC QLQ-CR29
5 years after surgery
Quality of Life 6
Time Frame: 8 years after surgery
The impact of sexual disorders in QoL was evaluated using EORTC QLQ-CR29
8 years after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2004

Primary Completion (Actual)

January 1, 2012

Study Completion (Actual)

January 1, 2020

Study Registration Dates

First Submitted

February 8, 2021

First Submitted That Met QC Criteria

February 8, 2021

First Posted (Actual)

February 12, 2021

Study Record Updates

Last Update Posted (Actual)

February 12, 2021

Last Update Submitted That Met QC Criteria

February 8, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sexual Function Disturbances

Clinical Trials on Inferior Mesenteric Artery Preservation

3
Subscribe